[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342899-105":59,"doc-detail-342899-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cafs-associated-genes-cafgs-in-pancreatic-ductal-adenocarcinoma-pdac-and-novel-therapeutic-strategy-review","CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy - Review","","Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by prominent fibrosis and among the highest mortality rates in human cancers. Cancer-associated fibroblasts (CAFs) are central drivers of PDAC progression, and this review consolidates current molecular knowledge of PDAC CAFs and evaluates emerging therapeutic opportunities. CAF-associated genes (CAFGs) are organized by stromal specificity, reflecting stroma/epithelia expression ratios, and refined by single-cell transcriptomics into myCAFs, iCAFs, and minor subtypes with distinct markers, spatial programs, immune roles, and therapy-relevant biology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cafs-associated-genes-cafgs-in-pancreatic-ductal-adenocarcinoma-pdac-and-novel-therapeutic-strategy-review/342899/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cafs-associated-genes-cafgs-in-pancreatic-ductal-adenocarcinoma-pdac-and-novel-therapeutic-strategy-review/342899.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How are CAF-associated genes (CAFGs) classified in PDAC, and why does the classification matter?","Question",{"text":112,"@type":113},"CAFGs are initially categorized into three groups based on stromal specificity using stroma/epithelia expression ratios (SE ratios). This framework supports understanding how different CAF states contribute to PDAC biology and therapeutic targeting.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What distinguishes myCAFs from iCAFs in PDAC progression?",{"text":117,"@type":113},"myCAFs are located adjacent to tumor cells and are associated with myCAFs markers such as LRRC15, while iCAFs are more distant from tumor cells and marked by factors including PDPN and/or COL14A1. The review links these locations to distinct microenvironments such as hypoxia and acidity for iCAFs.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic implications arise from targeting CAF biology in PDAC?",{"text":121,"@type":113},"The review highlights that myCAFs depletion can increase cytotoxic T lymphocytes and enhance PD-L1 antibody treatments. It also emphasizes that CAF metabolism and epigenetic regulation offer additional potential avenues to prevent PDAC progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342899,1790198434,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Review  \nCAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy  \nKeishi Yamashita 1, * and Yusuke Kumamoto 2  \nCitation: Yamashita, K.; Kumamoto, Y. CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy. Int. J. Mol. Sci. 2024, 25, 6003 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25116003  \nAcademic Editor: Agnieszka B. Bialkowska  \nReceived: 11 April 2024  \nRevised: 24 May 2024  \nAccepted: 27 May 2024  \nPublished: 30 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Kitasato 1-15-1, Minami-ku, Sagamihara 252-0374, Japan  \n2 Department of General-Pediatric-Hepatobiliary Pancreatic Surgery, Kitasato University School of Medicine, Sagamihara 252-0374, Japan; [110kumakuma@gmail.com](110kumakuma@gmail.com)  \n* Correspondence: [keishi23@med.kitasato-u.ac.jp](keishi23@med.kitasato-u.ac.jp)  \nAbstract: Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive cancer with striking fibrosis, and its mortality rate is ranked second across human cancers. Cancer-associated fibroblasts (CAFs) play a critical role in PDAC progression, and we reviewed the molecular understanding of PDAC CAFs and novel therapeutic potential at present. CAFs-associated genes (CAFGs) were tentatively classified into three categories by stroma specificity representing stroma/epithelia expression ratios (SE ratios) . The recent classification using single cell transcriptome technology clarified that CAFs were composed of myofibroblasts (myCAFs), inflammatory CAFs (iCAFs), and other minor ones (e.g., POSTN-CAFs and antigen presenting CAFs, apCAFs) . LRRC15 is a myCAFs marker, and myCAFs depletion by diphtheria toxin induces the rapid accumulation of cytotoxic T lymphocytes (CTLs) and therefore augment PDL1 antibody treatments. This finding proposes that myCAFs maybe a critical regulator of tumor immunity in terms of PDAC progression. myCAFs are located in CAFs adjacent to tumor cells, while iCAFs marked by PDPN and/or COL14A1 are distant from tumor cells, where hypoxic and acidic environments being located in iCAFs putatively due to poor blood supply is consistent with HIF1A and GPR68 expressions. iCAFs may be shared with SASP (secretion-associated phenotypes) in senescent CAFs. myCAFs are classically characterized by CAFGs induced by TGFB1, while chemoresistant CAFs with SASP may dependent on IL6 expression and accompanied by STAT3 activation. Recently, it was found that the unique metabolism of CAFs can be targeted to prevent PDAC progression, where PDAC cells utilize glucose, whereas CAFs in turn utilize lactate, which may be epigenetically regulated, mediated by its target genes including CXCR4 . In summary, CAFs have unique molecular characteristics, which have been rigorously clarified as novel therapeutic targets of PDAC progression.  \nKeywords: CAFs; PDAC; SPARC; LRRC15; myCAFs; iCAFs; metabolism  \n1. Introduction  \nPancreatic ductal adenocarcinoma (PDAC) is the most aggressive cancer with striking fibrosis, and its mortality rate is ranked second across human cancers [1] . Significant recurrent mutations were identified inKRAS followed by TP53, CDKN2A (p16), and SMAD4 in PDAC, where mutation rates of both KRAS and TP53 were confirmed as 93% and 72%, respectively [2] . The matched germline exome sequencing data clarified alterations in known germline predisposition genes such as BRCA1 and BRCA2 . As a result, pathogenic germline mutations were confirmed in 8","cbCaissEzEijRGVU","https://ap.wps.com/l/cbCaissEzEijRGVU","pdf",1806508,18,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"How are CAF-associated genes (CAFGs) classified in PDAC, and why does the classification matter?\",\"answer\":\"CAFGs are initially categorized into three groups based on stromal specificity using stroma/epithelia expression ratios (SE ratios). This framework supports understanding how different CAF states contribute to PDAC biology and therapeutic targeting.\"},{\"question\":\"What distinguishes myCAFs from iCAFs in PDAC progression?\",\"answer\":\"myCAFs are located adjacent to tumor cells and are associated with myCAFs markers such as LRRC15, while iCAFs are more distant from tumor cells and marked by factors including PDPN and/or COL14A1. The review links these locations to distinct microenvironments such as hypoxia and acidity for iCAFs.\"},{\"question\":\"What therapeutic implications arise from targeting CAF biology in PDAC?\",\"answer\":\"The review highlights that myCAFs depletion can increase cytotoxic T lymphocytes and enhance PD-L1 antibody treatments. It also emphasizes that CAF metabolism and epigenetic regulation offer additional potential avenues to prevent PDAC progression.\"}]","CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy - Review | PDF",1790048723,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89abff8307915b6e30317a129e7527e4.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d696419f4ff623b694f247474aaaff11.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/329c5a25f65fc5c5077b57124d91f48b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cb5f8db160ef94ac2d0a40c260e3193.webp",980,1385]